atomoxetine hydrochloride has been researched along with Autism in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Baweja, R; Hameed, U; Klein, M; Mattison, RE; Mayes, SD; Memon, H; Waschbusch, D; Waxmonsky, JG | 1 |
| Coskun, M; Gülle, ZN; Karayagmurlu, A | 1 |
| Chadman, KK; Guariglia, SR; Stapley, NW | 1 |
| Anagnostou, E; Baribeau, DA | 1 |
| Ago, Y; Hara, Y; Hasebe, S; Hashimoto, H; Katashiba, K; Matsuda, T; Onaka, Y; Takano, E; Takuma, K; Taruta, A | 1 |
| Charnsil, C | 1 |
| Ghanizadeh, A | 1 |
| Aman, MG; Arnold, LE; Cook, AM; Hall, KL; Ramadan, Y; Thompson, S; Witwer, AN | 1 |
| Maynard, M; McDougle, CJ; Posey, DJ; Stigler, KA; Wiegand, RE; Wilkerson, J | 1 |
| Corfield, A; Damodharan, SK; Joji, R; Niederhofer, H | 1 |
| McCarthy, J | 1 |
3 review(s) available for atomoxetine hydrochloride and Autism
| Article | Year |
|---|---|
An update on medication management of behavioral disorders in autism.
Topics: Adolescent; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Autistic Disorder; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Humans; Piperazines; Propylamines; Quinolones; Risperidone | 2014 |
Atomoxetine for treating ADHD symptoms in autism: a systematic review.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child, Preschool; Comorbidity; Humans; Propylamines | 2013 |
Children with autism spectrum disorders and intellectual disability.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Central Nervous System Stimulants; Child; Humans; Intellectual Disability; Methylphenidate; Prevalence; Propylamines | 2007 |
1 trial(s) available for atomoxetine hydrochloride and Autism
| Article | Year |
|---|---|
Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Pilot Projects; Propylamines | 2006 |
7 other study(ies) available for atomoxetine hydrochloride and Autism
| Article | Year |
|---|---|
Symptom scores and medication treatment patterns in children with ADHD versus autism.
Topics: Adolescent; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Central Nervous System Stimulants; Child; Child, Preschool; Female; Humans; Male; Psychotropic Drugs | 2020 |
Raynaud's Phenomenon Related with Atomoxetine Treatment in a Child with Autism and Attention-Deficit/Hyperactivity Disorder.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Problem Behavior; Raynaud Disease | 2019 |
Cued and contextual fear conditioning in BTBR mice is improved with training or atomoxetine.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Autistic Disorder; Conditioning, Classical; Cues; Disease Models, Animal; Fear; Learning; Male; Mice; Propylamines; Social Behavior | 2013 |
Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism.
Topics: Animals; Atomoxetine Hydrochloride; Autistic Disorder; Behavior, Animal; Dendritic Spines; Disease Models, Animal; Dopamine; Female; Humans; Interpersonal Relations; Male; Methylphenidate; Mice; Mice, Inbred ICR; Norepinephrine; Prefrontal Cortex; Pregnancy; Receptors, Dopamine D1; Recognition, Psychology; Valproic Acid | 2016 |
Efficacy of atomoxetine in children with severe autistic disorders and symptoms of ADHD: an open-label study.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Central Nervous System Stimulants; Child; Female; Humans; Male; Pilot Projects; Propylamines; Treatment Outcome | 2011 |
Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Asperger Syndrome; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Body Weight; Child; Child Development Disorders, Pervasive; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intelligence; Irritable Mood; Male; Neuropsychological Tests; Pilot Projects; Propylamines; Prospective Studies; Treatment Outcome | 2006 |
Atomoxetine treating patients with Autistic disorder.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attitude to Health; Autistic Disorder; Child; Child Behavior Disorders; Cost of Illness; Empathy; Family Health; Grief; Group Homes; Humans; Interviews as Topic; Parents; Propylamines; Residential Treatment; Social Isolation | 2006 |